Vivid Seats Inc
For the period ended Jun 30, 2024. Filed Aug 6, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 6, 2024
SEAT$1.49-1.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| Cash flows from operating activities | ||
|---|---|---|
| Net income | $9,518 | $68,598 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | 20,985 | 5,302 |
| Amortization of leases | 843 | 295 |
| Amortization of deferred financing costs | 453 | 453 |
| Equity-based compensation expense | 27,600 | 12,910 |
| Change in fair value of warrants | (1,761) | 673 |
| Loss on asset disposals | 122 | 17 |
| Deferred taxes | 156 | (24,577) |
| Change in fair value of derivative asset | 81 | — |
| Non-cash interest income | (291) | — |
| Foreign currency revaluation loss | 5,798 | — |
| Change in fair value of contingent consideration | — | (1,018) |
| Change in assets and liabilities: | ||
| Accounts receivable – net | (10,644) | (9,770) |
| Inventory – net | (9,245) | (15,227) |
| Prepaid expenses and other current assets | 2,541 | (16,696) |
| Accounts payable | 10,084 | 42,905 |
| Accrued expenses and other current liabilities | (25,803) | 13,586 |
| Deferred revenue | (4,505) | (1,913) |
| Other non-current assets and liabilities | (573) | 7,132 |
| Net cash provided by operating activities | 25,359 | 82,670 |
| Cash flows from investing activities | ||
| Purchases of property and equipment | (378) | (606) |
| Purchases of personal seat licenses | (737) | (486) |
| Investments in developed technology | (9,433) | (4,491) |
| Net cash used in investing activities | (10,548) | (5,583) |
| Cash flows from financing activities | ||
| Payments of February 2022 First Lien Loan | (689) | (1,375) |
| Repurchase of common stock as treasury stock | (20,069) | (7,612) |
| Tax distributions | (6,414) | (11,016) |
| Payments of Shoko Chukin Bank Loan | (2,655) | — |
| Payments for taxes related to net settlement of equity incentive awards | (565) | — |
| Proceeds from June 2024 First Lien Loan | 125,500 | — |
| Payments of deferred financing costs and other debt-related costs | (315) | — |
| Payment of liabilities under Tax Receivable Agreement | (77) | — |
| Cash paid for milestone payments | — | (2,500) |
| Net cash provided by (used in) financing activities | 94,716 | (22,503) |
| Impact of foreign exchange on cash, cash equivalents, and restricted cash | (1,536) | — |
| Net increase in cash, cash equivalents, and restricted cash | 107,991 | 54,584 |
| Cash, cash equivalents, and restricted cash – beginning of period | 132,434 | 252,290 |
| Cash, cash equivalents, and restricted cash – end of period | $240,425 | $306,874 |
| Supplemental disclosure of cash flow information: | ||
| Cash paid for interest | $16,108 | $7,261 |
| Cash paid for income tax | $3,285 | $401 |
| Cash paid for operating lease liabilities | $1,527 | $459 |
| Right-of-use assets obtained in exchange for lease obligations | $935 | $— |
| Establishment of liabilities under Tax Receivable Agreement | $— | $98,977 |
| Establishment of deferred tax asset under Tax Receivable Agreement and Secondary Offering | $— | $52,845 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.